Skip to content

JC virus (Progressive multifocal leukoencephalopathy)

JC virus (Progressive multifocal leukoencephalopathy)


0 / 19 complete


1 / 4 complete
High Yield Notes
3 pages

JC virus (Progressive multifocal leukoencephalopathy)

19 flashcards

USMLE® Step 1 style questions USMLE

4 questions

USMLE® Step 2 style questions USMLE

3 questions

A 48-year-old woman comes to the office with her sister who is concerned about a deterioration in her general status. The patient was diagnosed with HIV seven years ago. She says that her last T cell count was "good enough," so she has been been skipping every other dose of her antiretroviral medications and trimethoprim-sulfamethoxazole. Her sister has had to drive her home from work several times this month because she has become disoriented and confused about her surroundings. Motor strength is 4/5 on the right and 3/5 on the left. She is able to walk unassisted, but her gait appears mildly uncoordinated. There is diplopia when the right eye is covered. Her CD4 count is 75 cells/μL. MRI shows numerous asymmetric, hyperintense, non-enhancing lesions bilaterally without mass effect. Brain biopsy shows demyelination and atypical astrocytes. Which of the following is most likely responsible for this patient's current condition?

External References

In progressive multifocal leukoencephalopathy, progressive means that the disease worsens over time, multifocal means the disease affects multiple locations, leuko refers to white, and encephalopathy refers to a disease of the brain.

So progressive multifocal leukoencephalopathy or simply PML, is a disease of the white matter of the brain that affects multiple locations and worsens over time.

If we look at a cross section of the brain, it can be divided into two areas: the outermost area is the grey matter, which is made up of neuron cell bodies, and the innermost area is the white matter, which is made up of the axons that come off of the neuron cell bodies.

The axons transmit electrical impulses to the next neuron in the series.

The axons are surrounded by a fatty protective sheath called myelin that helps increase the speed at which electrical impulses are sent.

Myelin is produced by a special type of cells called oligodendrocytes.

The cause of progressive multifocal leukoencephalopathy is the John Cunningham virus, or simply JC virus, named after the first patient in whom the virus was identified.

JC virus is a non-enveloped virus with closed circular double-stranded DNA genome.

It’s thought that the virus is transmitted from person to person through the respiratory and gastrointestinal tract, and that it then moves through the bloodstream and eventually reaches kidney epithelial cells.

JC virus enters these kidney cells and starts replicating, but the cytotoxic CD8+ T cells of our immune system keep the virus in check by killing any cell that has replicating JV virus.

So to be clear, the virus is not eliminated, but instead it remains latent in the kidneys, meaning that it isn’t dividing and causing disease.

And It turns out that the vast majority of the population is infected by JC virus - that might include you!

Most people with a healthy immune system are able to keep JC virus in the latent phase in the kidney epithelial cells for their entire life. But things can change if the immune system gets weakened.

This can happen for various reasons, like an HIV-infected individual who loses T cells, or individuals taking immunosuppressive medications like monoclonal antibodies such as natalizumab, which is typically used to treat multiple sclerosis, and rituximab, which is used to treat various cancers and autoimmune diseases.

The JC virus is a type of human polyomavirus and is genetically similar to BK virus. It was named using the two initials of a patient, John Cunningham, with progressive multifocal leukoencephalopathy (PML). The virus causes PML and other diseases only in cases of immunodeficiency, as in AIDS or during treatment with drugs intended to induce a state of immunosuppression (e.g. organ transplant patients).